Accession Number: | 0000899243-20-020428 |
Date: | 2020-07-22 |
Issuer: | MERRIMACK PHARMACEUTICALS INC (MACK) |
Original Submission Date: |
ANDERSEN ERIC
5900 WILSHIRE BOULEVARD, SUITE 650
LOS ANGELES, CA 90036
WESTERN STANDARD LLC
5900 WILSHIRE BOULEVARD, SUITE 650
LOS ANGELES, CA 90036
WESTERN STANDARD PARTNERS LP
5900 WILSHIRE BOULEVARD, SUITE 650
LOS ANGELES, CA 90036
WESTERN STANDARD PARTNERS QP, L.P.
5900 WILSHIRE BOULEVARD, SUITE 650
LOS ANGELES, CA 90036
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-22 | P | 62,775 | a | $3.20 | 755,543 | indirect | f1 | |
COMMON STOCK | 2020-07-22 | P | 63,903 | a | $3.04 | 819,446 | indirect | f1 | |
COMMON STOCK | 2020-07-22 | P | 17,404 | a | $3.20 | 193,990 | indirect | f2 | |
COMMON STOCK | 2020-07-22 | P | 33,192 | a | $3.04 | 227,182 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the shares are directly held by wsp. the general partner of the funds is western standard. the managing member of western standard and the portfolio manager to the funds is mr. andersen. each of western standard and mr. andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares. |
f2 | the shares are directly held by wsp qp. the general partner of the funds is western standard. the managing member of western standard and the portfolio manager to the funds is mr. andersen. each of western standard and mr. andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares. |
f3 | the purchase of the securities referenced in this form 4 were conducted in a private transaction between gary crocker and certain family members and affiliates as the sellers and each of western standard partners, l.p., western standard partners qp, l.p., newtyn partners, lp, and newton partners te, lp as the purchasers. gary crocker is president and chairman of merrimack pharmaceuticals, inc. (the "company"). eric andersen, a member of the company's board of directors, is managing member of western standard llc, the investment manager for each of western standard partners l.p. and western standard partners qp l.p. noah levy, a member of the company's board of directors, is managing member of newtyn management, llc, the investment manager for newtyn partners, lp, and newton partners te, lp. |